• A Comparison of The Nice Highly Specialised Technology (HST) Programme with Assessment By The National Authority For Health (HAS; France), And The Federal Joint Committee (G-BA; Germany)

    Oct 1, 2017, 00:00

  • Economic Burden Of Vaccine Preventable Infectious Diseases Among Elderly Patients In Dutch Hospitals

    Oct 1, 2017, 00:00

  • Outcomes in Contact Force Technology Use For Cardiac Ablation – Role of Procedure Volume

    Oct 1, 2017, 00:00

  • Easipro3 – Enhancing Satisfaction With Prostate Cancer Treatment Decision With The Mobile Health Program Prostana- A Multicenter Randomized Controlled Trial

    Oct 1, 2017, 00:00

  • Current and Potential Future Changes In The Methodology of Emerging Value Frameworks

    Oct 1, 2017, 00:00

  • Geografia Do Gasto Público COM Nefrologia No Brasil 2013 A 2016

    Oct 1, 2017, 00:00

  • tackling Network Meta-Analysis Methodological Challenges- A Case Study On Biologic Treatments For Moderate To Severe Plaque Psoriasis In Children And Young People

    Oct 1, 2017, 00:00

  • Secukinumab Vs Adalimumab for the Treatment of Ankylosing Spondilytis- A Cost Per Responder Analysis at 52 Weeks from a Moroccan Perspective

    Oct 1, 2017, 00:00

  • Variation In Health Technology Assessment And Reimbursement Decisions In England, France, And Germany- Spotlight On The Impact Of Uncertainty

    Oct 1, 2017, 00:00

  • Incidence and Prevalence of Painful Diabetic Neuropathy and Postherpetic Neuralgia in Major 5 European Countries, the United States and Japan

    Oct 1, 2017, 00:00

  • Assessing The Burden of Disease In Peripheral And Axial Spondyloarthritis In Brazil

    Oct 1, 2017, 00:00

  • Continuous Subcutaneous Infusion Versus Multiple Dose Injection of Insulin For Newly-Diagnosed T1D Paediatric Patients- A Cost-Utility Analysis

    Oct 1, 2017, 00:00

  • Estimating Long-Term Survival in the Face of Immature Data- A Case Study of Nivolumab in Second Line Renal Cell Carcinoma

    Oct 1, 2017, 00:00

  • Reported Utilities for Patients with Untreated Advanced/Metastatic Renal Cell Carcinoma – A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Real World Data Analysis of Type 2 Diabetes Mellitus Treatment In An Integrated Health District

    Oct 1, 2017, 00:00

  • Analysis of Clinical And Economic Effectiveness of Statins For Secondary Prevention of Cardiovascular Disease In Kazakhstan

    Oct 1, 2017, 00:00

  • Economic Evaluation of Abiraterone in Metastatic Castration-Resistant Prostate Cancer in Patients With None/Mild Symptoms After Failure of Androgen Deprivation Therapy

    Oct 1, 2017, 00:00

  • Public Health And Economic Benefits Of Quadrivalent Influenza Vaccine In Mexico

    Oct 1, 2017, 00:00

  • Clinical Pharmacy Services And Workforce Requirements At Ministry Of Health Hospitals During Ten Years Mass Gathering Hajj (2006-2015) In Makah And Al-Medina Regions, Saudi Arabia

    Oct 1, 2017, 00:00

  • Use of Abiraterone And Enzalutamide In Metastatic Castration-Resistant Prostate Cancer In Routine Clinical Practice

    Oct 1, 2017, 00:00

  • Treatment Of Patients With Rheumatoid Arthritis- Real World Population-Based Evidence From France

    Oct 1, 2017, 00:00

  • Evaltuation of The National Drug Formularium and Electronic Catalog For The Indonesian UHC

    Oct 1, 2017, 00:00

  • Analysis of Consumption of Anti-TB Medicines in Ukraine During 2012-2016

    Oct 1, 2017, 00:00

  • Characterising the Relative Impact of Established Cardiovascular Disease and Chronic Kidney Disease on Quality of Life in Diabetes Patients

    Oct 1, 2017, 00:00

  • Assessment of Economic Model Stability By Repeated One-Way Sensitivity Analysis

    Oct 1, 2017, 00:00

  • Experiences With Price Competition Of Biosimilar Drugs In Hungary

    Oct 1, 2017, 00:00

  • Comparative Effectiveness And Medical Cost of Dabigatran Versus Vitamin K Antagonists From Engel 2- A French Nationwide Cohort Of 100,000 Patients With Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Cost-Utility Of Prasugrel Compared To Clopidogrel For Preventing Cardiovascular Events In Diabetic Patients With Acute Coronary Syndrome In Brazil

    Oct 1, 2017, 00:00

  • Current Situation And Development Of Chronic Diseases In China

    Oct 1, 2017, 00:00

  • Using Observational Data From Registry In Cost-Effectiveness Evaluation of Metastatic Castration Resistant Prostate Cancer In France

    Oct 1, 2017, 00:00

  • First-Line Pembrolizumab in PD-L1 Positive Non-Small Cell Lung Cancer- A Cost-Effectiveness Analysis from A UK Healthcare Perspective

    Oct 1, 2017, 00:00

  • Diagnosis Of Patients With Duchenne Muscular Dystrophy (DMD)- Results From A Global Survey Of Healthcare Providers From Nine Countries

    Oct 1, 2017, 00:00

  • Knowledge And Confidence Of Healthcare Providers Working At Hospitals About Appropriate Prescribing For Geriatrics

    Oct 1, 2017, 00:00

  • A Comparative Analysis Of The Health Care Utilization And Costs Of Patients Diagnosed With And Without Liver Cancer In The US Medicare Population

    Oct 1, 2017, 00:00

  • Hospital Burden 18 Months after Surgical Treatment of Functional Menorrhagia in France

    Oct 1, 2017, 00:00

  • How To Address French Health Authority (HAS/CEESP) Specific Requirements In Modelling Relapsing-Remitting Multiple Sclerosis In Health-Economic Evaluation? Modelling Treatment Sequences

    Oct 1, 2017, 00:00

  • Treatment interruption of Biological Drugs in Rheumatoid Arthritis- An Assessment of Case-Reports

    Oct 1, 2017, 00:00

  • The Novel Generation And Validation of Survival Curves In Oncology Utilizing Electronic Medical Records Linked To Point of Service Claims Data

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis of Enzalutamide and Abiraterone for Treatment of Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer

    Oct 1, 2017, 00:00

  • Preferences of Parents To Avoid Oral Health Outcomes In Children- Results of A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Economic Assessment of NT-PROBNP Test for Acute Heart Failure at Brazilian Private Payer Perspective

    Oct 1, 2017, 00:00

  • What Can Be Done for Access and Reimbursement Processes To Reward Innovation In Digital “Beyond The Pill” Solutions?

    Oct 1, 2017, 00:00

  • Do Countries With Similar GDPS And Health Expenditures Reimburse The Same Cancer Drugs?

    Oct 1, 2017, 00:00

  • Prospective Assessment of The Accuracy, Reliability and Cost-Effectiveness of Staging Non-Small Cell Lung Cancer (NSCLC) Only with The Combination of Pet/Ct and Brain MRI

    Oct 1, 2017, 00:00

  • Listening to the “Patient Voice” to Improve Design and Interpretation of Secondary Analyses- An Example in Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Insertable Cardiac Monitor Versus Standard of Care For Detection Of Atrial Fibrillation In Patients Following Cryptogenic Stroke- A Dutch Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Analysing Uptake Of New Medicine Service In English Community Pharmacies

    Oct 1, 2017, 00:00

  • Reliability, Validity and Responsiveness of A New Measure of Neck Disability (ND10)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness and Budget Impact of New Therapies for Metastatic Melanoma in Italy

    Oct 1, 2017, 00:00

  • Cost-Comparison Between the Etonogestrel Implant and the Medroxyprogesterone Acetate Injectable- Number of Unintended Pregnancies and Financial Impact

    Oct 1, 2017, 00:00

  • Modelling the Societal Impact of Secukinumab in Patients with Psoriatic Arthritis in Germany

    Oct 1, 2017, 00:00

  • Direct Costs Of Inflammatory Bowel Diseases Therapy In Poland - Nationwide Database Analysis

    Oct 1, 2017, 00:00

  • Impact of Different Baseline Definitions on The Incidence of Relevant Outcomes Associated with Cancer Following An Advanced Non-Small Cell Lung Cancer (NSCLC) Diagnosis

    Oct 1, 2017, 00:00

  • An Algorithm To Develop Correlated Multivariate Non-Normal (E.G. Beta, Gamma, Log-Normal) Distributions To Be Used In Probabilistic Sensitivity Analyses (PSAS)

    Oct 1, 2017, 00:00

  • Secondary Prevention Cardiovascular Patients In Ireland - Population Characteristics For Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Trucs And CAR-TS - The Emergence Of Io Cell Therapies

    Oct 1, 2017, 00:00

  • Evaluating The Real-Life Daily-Cost of Treatment With Antiepileptic Drugs In Fran A Study Based on The Combination Of French National Health Insurance Public Database, and The EMR LPD Private Database

    Oct 1, 2017, 00:00

  • Validity of Change In Recall Period For The Norfolk QOL Patient Reported Outcome (PRO) Measure

    Oct 1, 2017, 00:00

  • Análisis De Impacto Presupuestario De 2 Métodos De Screening De Cáncer De Cuello Uterino Basados En Test De Hpv En Argentina

    Oct 1, 2017, 00:00

  • Single Versus Multiple Inhalers in Patients with Chronic Obstructive Pulmonary Disease (COPD)- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Anti-Thrombotic Therapy For Patients With Venous Thromboembolism In A Nationwide Health Plan

    Oct 1, 2017, 00:00

  • Efficacy of Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease- Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Estimated Clinical Impact Of Two Oncologic Drug Shortages

    Oct 1, 2017, 00:00

  • Reducing Cognitive Burden In Discrete Choice Experiments

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Inflectra® Vs. Remicade® for Ankylosing Spondylitis in Germany

    Oct 1, 2017, 00:00

  • Evaluating Patients’ Preferences for Dulaglutide Versus Insulin Glargine Profiles in the United Kingdom- A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Comparison of Utility Values Implemented in Disease Models of Metastatic Melanoma

    Oct 1, 2017, 00:00

  • Cost-Minimization of Adalimumab and Infliximab In Patients With Moderate To Severe Ulcerative Colitis Refractory To Conventional Therapy

    Oct 1, 2017, 00:00

  • A Predictive Model To Include Uncertainty In Mean Health Utilities Estimation- Impact Of Social Class, Body Mass Index And Chronic Diseases

    Oct 1, 2017, 00:00

  • Could Healthcoin Be A Revolution In Healthcare?

    Oct 1, 2017, 00:00

  • Drug Utilisation Study of Anti-Obesity Products Dispensed by Pharmacies in South Africa

    Oct 1, 2017, 00:00

  • Epidemiology of Psoriasis In Colombia- A Governmental Database Analysis

    Oct 1, 2017, 00:00

  • Disclosure of Traditional and Complementary Medicine Used During Pregnancy and the Postpartum Period to Healthcare Providers

    Oct 1, 2017, 00:00

  • Evaluation Of Patient- (PRO) And Observer-Reported Outcomes (OBSRO) Measures Regarding Acceptability And Palatability Of Eltrombopag In A Pediatric Population

    Oct 1, 2017, 00:00

  • Relevance of Surgical Interventions for Treatment of Obstructive Sleep Apnea in Germany

    Oct 1, 2017, 00:00

  • How Should We Value Orphan Drugs? Suggestions From A Large Public Opinion Survey

    Oct 1, 2017, 00:00

  • Hepatitis A and Hepatitis B Recombinant Vaccine Adherence In The United States

    Oct 1, 2017, 00:00

  • Unmet Pharmaceutical Needs During The Economic Crisis In Greece

    Oct 1, 2017, 00:00

  • HTA MCDA In The Treatment of Macular Edema

    Oct 1, 2017, 00:00

  • Patient-Reported outcomes from Phase 3 Baricitinib Ra-Begin Study- Latin American Subgroup Analysis

    Oct 1, 2017, 00:00

  • Análisis De La Relaciones De Mercado Entre El Seguro Obligatorio Y El Seguro Voluntario Para El Caso Colombiano

    Oct 1, 2017, 00:00

  • Extrapolation of Adult Data for Pediatric Drug Benefit Assessment In The Amnog Dossier In The Light of The New Amvsg

    Oct 1, 2017, 00:00

  • Hospitalisations Among A Cohort Of Patients With Heart Failure Versus An Age- And Sex-Matched Cohort Without Heart Failure In England- A Comparative Study Using Cprd Data

    Oct 1, 2017, 00:00

  • Severity Of Kidney Disease In Systemic Lupus Erythematosus

    Oct 1, 2017, 00:00

  • Burden of Disease on Chronic Heart Failure Patients- A Multinational Cross-Sectional Survey in Real World Setting

    Oct 1, 2017, 00:00

  • Budget Impact of Introducing Secukinumab In The Treatment of Moderate-To-Severe Plaque Psoriasis From The Private Payer Perspective In Brazil

    Oct 1, 2017, 00:00

  • Burden Of Ulcerative Colitis In Japan

    Oct 1, 2017, 00:00

  • Burden Of Cardiovascular Disease (CVD) For Patients With Familial Hypercholesterolemia (FH) Or Atherosclerotic Cardiovascular Disease (ASCVD) And The Impact Of Reducing Low Density Lipoprotein-Cholesterol (LDL-C) Lowering In Latin American ...

    Oct 1, 2017, 00:00

  • Effect of Health System, Financing, and Macro-Economic Characteristics on The Migration of Foreign Physicians To Oecd Countries

    Oct 1, 2017, 00:00

  • Assessing the Economic and Humanistic Burden of Psoriatic Arthritis in Brazil

    Oct 1, 2017, 00:00

  • A Multi-Dimensional Assessment of the Conservative Technologies Used for the Treatment of Uterine Fibroids in Italy

    Oct 1, 2017, 00:00

  • Merkel Cell Cancer- Poor Response To Chemotherapy Exposes Significant Unmet Need

    Oct 1, 2017, 00:00

  • An Analysis of Translation Challenges When Adapting The Picture Naming Subtest of The Repeatable Battery for The Assessment of Neuropsychological Status (RBANS) for Use In Multinational Studies

    Oct 1, 2017, 00:00

  • The Choice of Effectiveness Criteria Affects Conclusions of Economic Evaluation of Health Care Innovations- Example Based on A Randomised Multicenter Trial Comparing Two Reduced Intensity Conditioning Regimen (FLU-BU-ATG) Vs. (FLU-TBI) For ...

    Oct 1, 2017, 00:00

  • Evaluación De Efectividad Y Seguridad De La Terapia Farmacológica Para EL Tratamiento De La Enfermedad De Parkinson Inicial Y Avanzada En Colombia

    Oct 1, 2017, 00:00

  • Secukinumab vs Adalimumab for The Treatment of Psoriatic Arthritis- A Cost Per Responder Analysis At 48 Weeks from A Chilean Perspective

    Oct 1, 2017, 00:00

  • Investigating The Economic Impact Of HIV-Associated Renal And Bone Co-Morbidities In UK Inpatients Using The Hes Database

    Oct 1, 2017, 00:00

  • Does Access To Highly Specialised Medicines Decline In A Northerly Direction?

    Oct 1, 2017, 00:00

  • The Economic Burden of Different Multiple Sclerosis Phenotypes

    Oct 1, 2017, 00:00

  • The Epidemiology Of Adult Immune (Idiopathic) Thrombocytopenic Purpura (ITP) In Finland- Resource Utilisation, Related Costs And Hospital Medication Associated With The Treatment Of Non-Splenectomised Adult Itp Based On Real World Data From ...

    Oct 1, 2017, 00:00

  • Budget Impact Model of Secukinumab for Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis Treatment in Italy

    Oct 1, 2017, 00:00

  • The Cost Of Illness For Invasive Meningococcal B Disease In Germany

    Oct 1, 2017, 00:00

  • Treatment Satisfaction and Burden of Illness With Oral Vs Injectable Multiple Myeloma Therapy in Patients with Newly Diagnosed Disease (NDMM)

    Oct 1, 2017, 00:00

  • Variation Trend of Annual Medical Cost Forseveralkinds of Malignant Tumors in China- Analysis Based on A Regional Public Health Insurance Claim Database (2011-2015)

    Oct 1, 2017, 00:00

  • The Comparative Cost-Effectiveness of Cabozantinib, Everolimus and Axitinib in Advanced Renal Cell Carcinoma (ARCC) After Failure of Prior Therapy- Scottish Perspective

    Oct 1, 2017, 00:00

  • A Minimally Invasive Hemodynamic Monitoring Device for the Brazilian Health System- Is Flotrac® Cost-Effective?

    Oct 1, 2017, 00:00

  • Calibrating Model-Consistent Transition Probabilities For Fibrosis Stages In NASH

    Oct 1, 2017, 00:00

  • A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatmetn of Psoriatic Arthritis at 48 Weeks from the Irish Payer Perspective

    Oct 1, 2017, 00:00

  • Análisis De Impacto Presupuestario Comparando 2 Métodos De Screening De Cáncer De Cuello Uterino EN EL Sector Público De Argentina

    Oct 1, 2017, 00:00

  • Clinical And Economic Benefit Of Upper Airway Stimulation For Obstructive Sleep Apnea In The German Setting

    Oct 1, 2017, 00:00

  • Safety And Effectiveness of Insulin Analogues Versus Human Insulin In Type 2 Diabetes; A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Work Productivity in Brazilian Patients with Moderate-to-Severe Plaque Psoriasis

    Oct 1, 2017, 00:00

  • Effect Of Pharmaceutical Care Intervention On Well-Being Index Of Type 2 Diabetes Outpatients In A Tertiary Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • A Conceptual Model For Pediatric Gastroesophageal Reflux

    Oct 1, 2017, 00:00

  • Patient and Tumor Profiles in The Brazilian Private Setting- Data from The Auditron Claims Database

    Oct 1, 2017, 00:00

  • Estimate European Candidates For Bronchoscopic Lung Volume Reduction (BLVR) Technologies In The Treatment Of Severe Emphysema

    Oct 1, 2017, 00:00

  • Adesão A Terapia Antihipertensiva E Qualidade De Vida

    Oct 1, 2017, 00:00

  • The Use of Real World Data for Nice Decision-Making- A Review of Submissions To Three Treatment Effectiveness Evaluation Programmes In 2015 And 2016

    Oct 1, 2017, 00:00

  • Burden of Lysosomal Acid Lipase Deficiency

    Oct 1, 2017, 00:00

  • Cost-Savings In Process Innovations; A Case Example In Myocardial Infarction Patients

    Oct 1, 2017, 00:00

  • Human Papilloma Virus In Italy- Cost Of Illness And Potential Savings Due To HPV9 Primary Prevention

    Oct 1, 2017, 00:00

  • Seal or Varnish? Cost-Effectiveness of Fissure Sealants Versus Fluoride Varnish in Preventing Dental Decay in Children

    Oct 1, 2017, 00:00

  • Do Nice Appeals Make A Difference? Impact of Appeals on Appraisal Outcomes

    Oct 1, 2017, 00:00

  • Clinical Comparison of First-Line Platin Chemotherapy Regimens In Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Using German Registry Data

    Oct 1, 2017, 00:00

  • Fast-Track Medication Refill (FTMR) Service Could Be More Cost-Effective Than The Current Model Of Care In Hong Kong

    Oct 1, 2017, 00:00

  • Improving Disease Detection Through Methods To Reduce Patient Heterogeneity

    Oct 1, 2017, 00:00

  • Investigating Comparator Requirements For Drug Selection For Cost-Effectiveness

    Oct 1, 2017, 00:00

  • The Impact of Disease Duration and Disease Activity on the Cost of Rheumatoid Arthritis- Results from Burden of Rheumatoid Arthritis Across Europe a Socioeconomic Survey (BRASS)

    Oct 1, 2017, 00:00

  • Gender Inequality In Acute Gastro-Enteritis Rates In England

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Pembrolizumab for The First-Line Treatment of Metastatic Non-Small Cell Lung Carcinoma in Portugal

    Oct 1, 2017, 00:00

  • Assessment Of Health Technology Appraisals To Identify Key Drivers For Reimbursement Of Oncology Drugs With Only Phase 2 Clinical Data

    Oct 1, 2017, 00:00

  • Disease Progression in Pediatric Multiple Sclerosis- A Narrative Review

    Oct 1, 2017, 00:00

  • POCT Cost Effectiveness Case Study On The Way To A Hb-Hta Unit

    Oct 1, 2017, 00:00

  • Pro Instruments used in Studies of Pulmonary Hypertension Since 1960

    Oct 1, 2017, 00:00

  • New Drugs Approval Timing In Italy (2015-2017)

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Enstilar® for The Treatment of Psoriasis In Italy

    Oct 1, 2017, 00:00

  • Cancer Drugs In Algeria And Six Other Countries- A Cross-Country Price Comparison Study

    Oct 1, 2017, 00:00

  • Reduced Needlestick Injuries And HBV Infections In Chinese Healthcare Workers From Blunt-Tip Suture Needles In Cesarean Sections- A Markov Simulation

    Oct 1, 2017, 00:00

  • Prescription Costs Associated with A Pediatrician-Led Care Model Serving Children with Medical Complexities (CMC)

    Oct 1, 2017, 00:00

  • EQ-5D-5L Population Norms For Moscow (Russia)- Interim Analysis

    Oct 1, 2017, 00:00

  • An Exploratory Comparison Of US And EU Approaches To Oncology Management. Are US Payers Ready For Management Tools Incorporating HTA Methodologies?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness and Modeling Approaches of Direct-Acting Antiviral Agents In Chronic Hepatitis C Infection- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • A Model To Predict Costs And Outcomes Associated With Hyperkalaemia In Patients With Chronic Kidney Disease Or Heart Failure

    Oct 1, 2017, 00:00

  • Systematic Literature Review On Multi-Indication Pricing Models In Oncological Drugs

    Oct 1, 2017, 00:00

  • Analysis of Metastatic Breast Cancer Policies to Advance Access To Treatment in Latin America- Research Methodology and Approaches used to Survey the Current Policy Environment

    Oct 1, 2017, 00:00

  • The Impact of Trial Design on Network Meta-Analysis and Decision-Making- A Working Example in Ulcerative Colitis

    Oct 1, 2017, 00:00

  • Implications of the German HTA-Process on Market-Uptake of Oral Treatments for Type-2-Diabetes (T2DM) Since 2007

    Oct 1, 2017, 00:00

  • Assessing The Real-World Hospital Economic Burden Of Spinal Muscular Atrophy (SMA) In France

    Oct 1, 2017, 00:00

  • An Observational Cross-Sectional Database Study To Estimate Hospitalization Costs Related To Cardiovascular Disease In Brazilian Private Healthcare System

    Oct 1, 2017, 00:00

  • A Comparison of Health Technology Assessment (HTA) Requirements For Systematic Literature Reviews (SLRS)

    Oct 1, 2017, 00:00

  • Feasibility And Acceptability Of Atrial Fibrillation Screening Using A Hand-Held ECG Device In General Practice Setting In Hong Kong

    Oct 1, 2017, 00:00

  • An Analysis of Health-Related Quality of Life in People with Multiple Sclerosis in Ireland

    Oct 1, 2017, 00:00

  • Household Storage Of Medicines And Associated Factors In Tigray Region, Northern Ethiopia

    Oct 1, 2017, 00:00

  • Custos Diretos No Tratamento De Câncer De Mama- Olhar Estratégico De Uma Operadora De Planos De Saúde Do Brasil

    Oct 1, 2017, 00:00

  • Role of Chemotherapy In The Current Treatment of Metastatic Melanoma

    Oct 1, 2017, 00:00

  • Impairment of Work Ability In Patients With Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Precision Cost-Effectiveness Analysis Of Radiofrequency Catheter Ablation In A Real-World Atrial Fibrillation Population

    Oct 1, 2017, 00:00

  • A Via Administrativa E Judicial Como Forma De Acesso Aos Medicamentos No Sistema Público De Saúde Brasileiro

    Oct 1, 2017, 00:00

  • Modelling For Rare Diseases- Case of Canakinumab In Periodic Fever Syndromes In France

    Oct 1, 2017, 00:00

  • Between-Hospital Variation of In-Hospital Mortality and 30-Day Readmissions in Acute Myocardial Infarction in Portugal- 2012-2014

    Oct 1, 2017, 00:00

  • Emerging Markets Tiered Pricing- A Quantitative Assessment Of Local Affordability And Existing Price To Patient

    Oct 1, 2017, 00:00

  • Target Organ Damage And The Long Term Effect of Nonadherence To Clinical Practice Guidelines In Patients With Hypertension- A Retrospective Cohort Study

    Oct 1, 2017, 00:00

  • Broadening The Valuation Space In Health Technology Assessment- The Case of Monitoring Individuals With Ocular Hypertension

    Oct 1, 2017, 00:00

  • Economic Burden Associated with Skeletal-Related Events in Patients with Bone Metastases in Colombia

    Oct 1, 2017, 00:00

  • Estimation Of The Cost Of Relapse In Schizophrenia- A Comparison Between Colombia, Panama And Mexico

    Oct 1, 2017, 00:00

  • Drug Commercialization Before The Pricing And Reimbursement In Italy- The Non Negotiated C Class (C-NN)

    Oct 1, 2017, 00:00

  • Retrospective Analysis of Hospital Episode Statistics Data To Estimate The Economic Burden of Vaginal and Vulval Cancer in England (2009-2015)

    Oct 1, 2017, 00:00

  • Does The Early Bird Catch The Worm- Early Cancer Detection And Survival In The UK

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis of An Increased Uptake of Alemtuzumab From The UK NHS Perspective

    Oct 1, 2017, 00:00

  • The Cystic Fibrosis Impact Questionnaire (CF-IQ)- Qualitative Development And Cognitive Evaluation Of A New Patient-Reported Outcome Instrument To Assess The Life Impacts Of Cystic Fibrosis

    Oct 1, 2017, 00:00

  • Real-World Multiple Myeloma Treatment Pattern In Lebanon- Evidence From Patient Chart Audit

    Oct 1, 2017, 00:00

  • Preferences for Route of Administration, Frequency and Location – A Time-Trade-Off Study in the United Kingdom General Population

    Oct 1, 2017, 00:00

  • Are There Differences in Fact-G Scores Between Different Tumour Types for an EU Population Using Real World Data?

    Oct 1, 2017, 00:00

  • Analysis Of Epidemiological Data On Burden Disease In Europe

    Oct 1, 2017, 00:00

  • Resource Utilization and Treatment of Patient with Hepatocelullar Carcinoma – A Microcosting Analysis

    Oct 1, 2017, 00:00

  • Seleção Sistemática De Coortes Em Bases De Dados Assistenciais

    Oct 1, 2017, 00:00

  • Evaluating The Economic Burden And Health Care Utilization Of Bacterial Pneumonia In The US Department Of Defense Population

    Oct 1, 2017, 00:00

  • Costo Efectividad Del USO De Ticagrelor Frente A Copidogrel En Pacientes CON Síndrome Coronario Agudo En Colombia

    Oct 1, 2017, 00:00

  • Investigation of Demographic Differences for Non-Small Cell Lung Cancer Patients with and Without Type 2 Diabetes

    Oct 1, 2017, 00:00

  • Observed Versus Estimated Acquisition Costs Associated with Medicines Recommended by the All Wales Medicines Strategy Group

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Polypill for Patients with or at High Risk of Cardiovascular Disease in an NHS Setting

    Oct 1, 2017, 00:00

  • Literature Review of The Cost of Dementia on China

    Oct 1, 2017, 00:00

  • Análise De Significância Do Banco De Dados Da Saúde Suplementar – Ss No Brasil, Sob As Perspectivas Dos Atendimentos Em Hospitais E Demais Prestadores Particulares

    Oct 1, 2017, 00:00

  • Epidemiology and Clinical Characterisation of Obsessive- Compulsive Disorder in Bahawalpur Pakistan

    Oct 1, 2017, 00:00

  • Attitude Of Pharmacy Educators Towards Complementary And Alternative Medicines (CAM) Education In Pharmacy Curriculum- A Qualitative Exploration

    Oct 1, 2017, 00:00

  • Reporting Of The Use Of Research And Publication Guidelines In Health Economic And Outcomes Research Publications In Inflammatory Bowel Disease – A Systematic Literature Review

    Oct 1, 2017, 00:00

  • The Impact of Rheumatoid Arthritis (RA) on a Patient’s Ability to Stay in Work and Level of Pain Experienced

    Oct 1, 2017, 00:00

  • Economic Evaluation of Nivolumab (NIVO) Plus Ipilimumab (IPI) Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada

    Oct 1, 2017, 00:00

  • A Novel Atrial Fibrillation Evaluation Modelling Solution For NHS

    Oct 1, 2017, 00:00

  • New Modelling Approaches In Ophthalmology- Partitioned Vision Distrbution Model In Symptomatic Vitreomacular Adhesion (VMA)/Vitreomacular Traction (VMT) With Or Without Full-Thickness Macular Hole (FTMH)

    Oct 1, 2017, 00:00

  • The Occurrence and Territorial Distribution of Acute Myocardial Infarctions in Hungary

    Oct 1, 2017, 00:00

  • Análise Situacional Do Tratamento Cirúrgico Do Câncer Colorretal No Brasil

    Oct 1, 2017, 00:00

  • Tratamento Clínico De Obesidade Através De Internações Clínicas Em Spa- Impacto Econômico Da Judicialização

    Oct 1, 2017, 00:00

  • Burden Of Respiratory Syncytial Virus (RSV) Disease In Adults- Final Analysis From A Retrospective Chart Review

    Oct 1, 2017, 00:00

  • Real World Effectiveness of Treatment With OBV/PTV/R ± DSV In HCV Patients With Cirrhosis In Poland

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness Of Tavi In Intermediate Risk Patients In France

    Oct 1, 2017, 00:00

  • A Systematic Review of Corticosteroids’ Role in the Management of Urolithiasis Patients

    Oct 1, 2017, 00:00

  • Efficacy and Safety of Interferon-Free Therapies For Chronic Hepatitis C Patients Coinfected With Hiv- Systematic Review of Clinical Trials

    Oct 1, 2017, 00:00

  • Cost Containment And Privatisation Of Pharmaceutical Care In Gree A Review Of Policy Reforms Under The Memorandums’ Requirements

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Results Of Highly Innovative Drugs Approved For Temporary Reimbursement In The Czech Republic

    Oct 1, 2017, 00:00

  • Assessing the Value of Decision Trees As A Method for Identifying Patient Subgroups

    Oct 1, 2017, 00:00

  • Medicine Prices Disparity Among Retail Pharmacies In Selangor, Malaysia

    Oct 1, 2017, 00:00

  • A Comparative Study Between Hypertensive Patients with and without Co-Morbidities; Knowledge, Acceptance of Illness and Quality of Life as Quantifiable Variables in KPK, Pakistan

    Oct 1, 2017, 00:00

  • Choice of Instrument Impacts Healthcare Decisions- Effect of Source of Utility Derived from the Same Patient Population on Cost-Effectiveness

    Oct 1, 2017, 00:00

  • Rare Diseases, Are Caregivers Just As Affected As Patients?

    Oct 1, 2017, 00:00

  • Internet Based Treatment of Depressive Symptoms – A Health Economic Evaluation of Costs and Benefits

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns In The Neurogenic Bladder Population- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Evolution Cost-Effectiveness Analysis of Pharmaceutical Care for Type 2 Diabetes Mellitus

    Oct 1, 2017, 00:00

  • Burden Of Disease, Healthcare Pathways And Costs Of Primary Progressive Multiple Sclerosis- An Italian Real World Study On 10 Million Inhabitants

    Oct 1, 2017, 00:00

  • Patient Preferences for Interferon-Beta in Iran- A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Inclusion of Comparator Single Arm Trials Used for Ema/Fda Registration In The Network Meta-Analysis Using Matching Adjusted Indirect Comparisons

    Oct 1, 2017, 00:00

  • Identification of Real World Data Sources in Cancer in the Nordic Countries

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Molecular Versus Conventional Screening For Acute Intestinal Infectious Diseases- Novel Application Of Agent-Based Modelling

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization And Cost Of Patients With Acute Coronary Syndromes In Tianjin, China

    Oct 1, 2017, 00:00

  • Crohn’s Disease in Germany- A Claims Data Analysis of Therapies with Biological Agents

    Oct 1, 2017, 00:00

  • The Prevalence Of Chronic Health Conditions And Multimorbidity In The Portuguese Population - Results From The 2014 National Health Interview Survey

    Oct 1, 2017, 00:00

  • Antimalarial Treatment Outcomes In Ethiopia- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Estimating The Excess Costs of Community-Acquired Pneumonia In Elderly People In Japan

    Oct 1, 2017, 00:00

  • Celebrity Deathmatch- Burden Of Disease VS RCTS In The Southern Cone Of Latin America

    Oct 1, 2017, 00:00

  • Development of A Patient-Reported Questionnaire In Patients With Chronic Pruritus

    Oct 1, 2017, 00:00

  • A Health Technology Assessment of Hyperthermic Intraperitoneal Chemotherapy Added to Interval Cytoreductive Surgery in Stage III Ovarian Cancer

    Oct 1, 2017, 00:00

  • Detection And Management Of Diabetes In England- Results From The Health Survey For England

    Oct 1, 2017, 00:00

  • External Reference Pricing In Greece. A Comparative Analysis For 2015-2017

    Oct 1, 2017, 00:00

  • Disease Burden Of Fractures In Patients With Osteoporosis In Japan

    Oct 1, 2017, 00:00

  • Are Accelerated Approval Mechanisms A Predictor To Early Access And Coverage? A Global Study Of Cancer Drugs

    Oct 1, 2017, 00:00

  • Neutrophil-To-Lymphocyte Ratio (NLR) As A Predictor For Recurrencein Patients With Stage Iii Melanoma

    Oct 1, 2017, 00:00

  • Desarrollo De Material Audiovisual Educativo Basado En La Evidencia Para Promover La Salud Materna Y Neonatal

    Oct 1, 2017, 00:00

  • Feasibility Of Precision Oncology Virtual Tumor Boards To Optimize Direct Point-Of-Care Management And Clinical Trial Enrollment Of Advanced Cancer Patients

    Oct 1, 2017, 00:00

  • Risky Business- What Factors Influence Decision-Maker’s Willingness to Pay for New Treatments on the Hospital Formulary?

    Oct 1, 2017, 00:00

  • Forecasting Pharmaceutical Expenditure In Europe- Adjusting For The Impact Of Rebates And Discounts

    Oct 1, 2017, 00:00

  • Varicella-Related Hospitalizations- Brazilian Retrospective Analysis After The Inclusion of A Vaccine in The National Immunization Program

    Oct 1, 2017, 00:00

  • Possibilities of Domestic Producers of The Republic of Kazakhstan In The Field of Manufacturing Anti-Tuberculosis Medicines

    Oct 1, 2017, 00:00

  • Novel Biologics Versus Conventional Preventive Therapies In Migraine- A Framework for Economic Evaluation

    Oct 1, 2017, 00:00

  • Quality of life improvement in a heart failure clinical program vs. Conventional management in a specialized clinic in colombia

    Oct 1, 2017, 00:00

  • Knowledge And Satisfaction Of Health Insurance Clients- Cross-Sectional Study Of A Tertiary Hospital Services In Ghana

    Oct 1, 2017, 00:00

  • Determinants Of The Relationship Between Improved Glucose Control And Modeled Health Outcomes In Type 2 Diabetes Simulation Models

    Oct 1, 2017, 00:00

  • Web App Estimating Cost Savings And Clinical Outcomes Of Blood Glucose Monitoring Program. Example From The UK

    Oct 1, 2017, 00:00

  • Comparison of Budesonide Inhalers For Treatment of Asthma In Adults And Adolescents In Russian Federation- Cost – Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns Of Patients With Ovarian Cancer Receiving First Line Chemotherapy In The United States

    Oct 1, 2017, 00:00

  • A UNIFORM PROBABILISTIC APPROACH TO MANAGE UNCERTAINTIES REGARDING VACCINE EFFECTIVENESS AGAINST SEROTYPE 3, 19A, NTHI AND HERD EFFECT IN THE BASE CASE OF A COST-EFFECTIVENESS ANALYSIS COMPARING NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D ...

    Oct 1, 2017, 00:00

  • Economic and Humanistic Burden of Illness Amongst Diabetes Patients Experiencing Treatment Inertia

    Oct 1, 2017, 00:00

  • Health Service Implications Of The Implementation Of An Early Discharge Strategy For Patients Admitted In Infectious Diseases Departments In Southern Europe

    Oct 1, 2017, 00:00

  • Redets. 10 Years Of Full Economic Health Technologies Assessments (Medical Devices) In Spain (2006-2016)

    Oct 1, 2017, 00:00

  • A Cost Effectiveness Analysis of Obinutuzumab In The Management of Chronic Lymphocytic Leukemia In Greece

    Oct 1, 2017, 00:00

  • Estimation of Prevalence In Rare Disease

    Oct 1, 2017, 00:00

  • Evaluation of Barriers To Effective Insulin Therapy Among Type 2 Diabetes Mellitus Patients

    Oct 1, 2017, 00:00

  • The Utility of Different Approachs to Developing Health Utilities Data in Childhood Rare Diseases – A Case Study in Spinal Muscular Atrophy (SMA)

    Oct 1, 2017, 00:00

  • The Impact of Scottish Medicines Consortium (SMC) Process Changes on Acceptance Rates for New Medicines for End of Life and Very Rare Conditions

    Oct 1, 2017, 00:00

  • The Comparison of EQ-5D-5L Versus Disease/Treatment-Specific Measures in Pulmonary Embolism and Deep Vein Thrombosis

    Oct 1, 2017, 00:00

  • The Economic Burden of Coeliac Disease in North America and Europe- A Systematic Review

    Oct 1, 2017, 00:00

  • The Use of Published Real-World Evidence In HTA- An Analysis Of The Evidence Base Of Company Submissions In 2016 Nice Appraisals

    Oct 1, 2017, 00:00

  • Economic Evaluation of Single Inhaler Triple Therapy For Patients With Chronic Obstructive Pulmonary Disease (COPD) Using The Galaxy Model

    Oct 1, 2017, 00:00

  • Iron Deficiency Anemia In Patients With Chronic Inflammatory Bowel Disease (IBD)- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Symptoms and Impacts in Metastatic Castration-Resistant Prostate Cancer- Qualitative Study Findings

    Oct 1, 2017, 00:00

  • Evaluating Patient Reported Outcomes Commonly Used In Current Lung Cancer Clinical Trials

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Nintedanib Versus Pirfenidone Treatment In Idiopathic Pulmonary Fibrosis In Turkey

    Oct 1, 2017, 00:00

  • Integrating Novel Screening Methods For Prostate Cancer, Cost-Utility Interventions

    Oct 1, 2017, 00:00

  • Determining The Brazilian Population Health Status- Estimate Of Health Production Function

    Oct 1, 2017, 00:00

  • How well does the leading pharmaceutical reform model work in china? --an interrupted time series analysis

    Oct 1, 2017, 00:00

  • Implementation of Nice Guidance for the Treatment of Type 2 Diabetes

    Oct 1, 2017, 00:00

  • Amnog Dossiers As A Challenge for Pharmaceutical Companies- Is There A Correlation Between Volumes and Added Medical Benefit?

    Oct 1, 2017, 00:00

  • Is it Possible to Accurately Identify Rare Diseases Using National Hospital Discharge Databases?

    Oct 1, 2017, 00:00

  • An Effective Tablet Program For Collecting Pain Data From Patients

    Oct 1, 2017, 00:00

  • Barriers to the Introduction of Actual Technologies for Induction of Labor Management

    Oct 1, 2017, 00:00

  • The Economic Impact Of Fibrin Sealants Used For Hemostasis In Coronary Artery Bypass Grafting Surgery; An Italian Perspective

    Oct 1, 2017, 00:00

  • MÉTODOS DE ANÁLISE MULTICRITÉRIO EMPREGADOS NA SELEÇÃO DE MEDICAMENTOS

    Oct 1, 2017, 00:00

  • Comparative Efficacy and Safety of Regimens for Treating Plasmodium Falciparum Malaria- A Systematic Review And Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Development And Evaluation Of Onconurse Practice− A Smartphone Application For Oncology Nurses

    Oct 1, 2017, 00:00

  • Using Mathematical Optimisation In Model-Based Cost-Effectiveness Analyses- A Case Study Of A Stratified Breast Screening Programme

    Oct 1, 2017, 00:00

  • Budget Impact Analysis For Switching From Manual To Pre-Filled Syringes For Catheter Maintenance

    Oct 1, 2017, 00:00

  • EQ-5D-5L Utility Values For Spanish Patients With Painful Chronic Osteoarthritis, Low-Back-Pain Or Cancer Pain

    Oct 1, 2017, 00:00

  • Utility Values Across Lines of Therapy in Immuno-Oncology Treatments- An Example from Advanced Melanoma

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis For The Treatmet with Daclatasvir-Asunaprevir in Patients Naive with Chronic Hepatitis C Genotype 1b Without Baseline Ns5a Polymorphisms Under The Public Payer Perspective in Mexico

    Oct 1, 2017, 00:00

  • Preliminary Results Of Benefits Study - Brazilian Economic Evaluation Of Sflt-1/Plgf Test For Preeclampsia Prediction And Diagnosis- Private Perspective

    Oct 1, 2017, 00:00

  • Age and Gender Relationships with Systemic Corticosteroid Induced Morbidity in Asthma- A Case-Control Study

    Oct 1, 2017, 00:00

  • Haemorrhoidal Artery Ligation Procedure For The Treatment of Symptomatic Grade II–III Heamorrhoids- A Trial-Based And Long-Term Model-Based Economic Evaluation

    Oct 1, 2017, 00:00

  • The Impact of Increase in The Proportion of Early Breast Cancer Cases on Costs and Outcomes

    Oct 1, 2017, 00:00

  • Pro-Ctcae Impact on Payer Evaluations of Oncologic Therapies- A Qualitative Research Study

    Oct 1, 2017, 00:00

  • Barreras Y Facilitadores Para La Cobertura De Peritoneodiálisis En Chile

    Oct 1, 2017, 00:00

  • Zoster Vaccine Effectiveness Against Incident Herpes Zoster and Post-Herpetic Neuralgia In Elderly In The UK

    Oct 1, 2017, 00:00

  • Relative Efficacy and Tolerability of Lacosamide Versus Levetiracetam as Monotherapy for Adults with Newly Diagnosed Focal Seizures- A Post-Hoc Analysis of Randomized Clinical Trials

    Oct 1, 2017, 00:00

  • Testosterone Replacement therapy As An Anti-Ageing Treatment for Men- A Literature Review and Economic Evaluation

    Oct 1, 2017, 00:00

  • Health Related Quality Of Life For Systemic Juvenile Idiopathic Arthritis (SJIA) Patients And Caregivers On Biologic Therapy, From A Caregiver’s Perspective

    Oct 1, 2017, 00:00

  • Costs of Major Complications of Type 2 Diabetes- A Systematic Review

    Oct 1, 2017, 00:00

  • Efectividad De Las Intervenciones En Cultura De Seguridad Del Paciente En Las Instituciones Hospitalarias- Revisión Sistemática

    Oct 1, 2017, 00:00

  • The Role of Patient-Reported Outcomes and Patient Engagement In Health Technology Assessments and Reimbursement Decision Making In 10 Countries

    Oct 1, 2017, 00:00

  • Elasticidad Precio De La Demanda Para Explorar Medidas Impositivas Que Desalienten EL Consumo De Bebidas Azucaradas Y Contribuyan a Prevenir Obesidad Y Diabetes Tipo II

    Oct 1, 2017, 00:00

  • Modelling The Burden of Cardiovascular Disease In Colombia And The Impact of Reducing Modifiable Risk Factors

    Oct 1, 2017, 00:00

  • Does the Real-World use of Pharmacological Therapy Follow Guidelines in Coronary Artery Disease Patients in Finland?

    Oct 1, 2017, 00:00

  • Analysis of the G-BA Decision-Making Criteria on the Benefit Assessment of Diabetes Treatments- Is Cost an Influencing Criterion?

    Oct 1, 2017, 00:00

  • Multiple Source of Information to Characterize the Clinical, Therapeutic Management and Economic Burden of Patients with Multiple Sclerosis in France

    Oct 1, 2017, 00:00

  • Competencies Of Formal Carers Regarding Basic Clinical And Soft Skills In The Provision Of Outpatient Services And Patients’ Perspective- The Two Sides Of The Same Coin

    Oct 1, 2017, 00:00

  • Clinical And Economic Outcomes Of Microinvasive Glaucoma Surgery (MIGS) With Stents In Patients With Mild-To-Moderate Or Refractory Glaucoma In Spain

    Oct 1, 2017, 00:00

  • Examination of The Effectiveness of Core Training Between Junior Women Basketball Players To Prevent Sports Injuries

    Oct 1, 2017, 00:00

  • Long-Term Cost-Effectiveness of Ideglira Versus Basal-Bolus Insulin As Intensification Therapies For People With Type 2 Diabetes Inadequately Controlled on Basal Insulin In Spain- Projections Based On The Dual VII Trial

    Oct 1, 2017, 00:00

  • Costos de la Fibrilación Auricular en Colombia

    Oct 1, 2017, 00:00

  • Can Missing Data Boundary Estimates Cast Doubt On Previous Conclusions Reevaluating A 10 Year Cost-Effectiveness Analysis (CEA) Of The Diabetes Prevention Program Outcomes Study (DPP/DPPOS)?

    Oct 1, 2017, 00:00

  • HTA Analysis of Intraocular Lenses After Cataract Surgery- Hydrophobic Vs. Hydrophilic Lenses - Health Technology Assessment In Slovak Healthcare Environment

    Oct 1, 2017, 00:00

  • Access and Secondary Use of Data Collected In An Electronic Medical Chart- Results Of The Real World Roswitch Study

    Oct 1, 2017, 00:00

  • An Updated Review Of The Health Economic Burden Of Varicella In Latin America And The Caribbean

    Oct 1, 2017, 00:00

  • Comparison of Persistence And Adherence In Biologic Naïve Patients With Psoriatic Arthritis Initiating Apremilast or Biologics In A US Administrative Claims Database

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Continuous Versus Intermittent Renal Replacement Therapy for Critically ILL Acute Kidney Injury Patients Under the Perspective of the Brazilian Private Healthcare System

    Oct 1, 2017, 00:00

  • The Use of Mcda In HTA Decision Making In Bulgaria

    Oct 1, 2017, 00:00

  • Economic Evaluation of Subcutaneous Methotrexate For Long-Term Treatment of Moderate-To-Severe Psoriasis In The United Kingdom

    Oct 1, 2017, 00:00

  • The Attitude Of Parents To Non-Mandatory Vaccinations

    Oct 1, 2017, 00:00

  • A Retrospective Claims Analysis on Rates of Compliance and Discontinuation Among Canadian Multiple Sclerosis Patients Treated with Disease-Modifying Therapies at 6, 12 and 24-Month Periods

    Oct 1, 2017, 00:00

  • Community Pharmacists' Interest In And Attitude To Pharmacy Practice Research In Ethiopia- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Preoperative MRI In Ductal Carcinoma In Situ of The Breast

    Oct 1, 2017, 00:00

  • Quality of Life (QOL), Functional Status (FS), and Survival in Triple Negative Breast Cancer (TNBC)- Discordance of Definitions Among a Targeted Literature Review and Stakeholder Interviews

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Assessment Of Herpes Zoster Vaccination In Germany

    Oct 1, 2017, 00:00

  • Centralized Procurement of Medical Devices In Italy- A Methodology Towards Standardized Tender Dossier

    Oct 1, 2017, 00:00

  • Impact Of Using External Reference Pricing (ERP) And Health Technology Assessment (HTA) As Part Of Cost-Containment Policies- Comparison Of Prices In Latin America

    Oct 1, 2017, 00:00

  • Study Of Polypharmacy At A Tertiary Care Teaching Hospital Bangalore

    Oct 1, 2017, 00:00

  • Economic Evaluation of Multi-Drug Resistant Tuberculosis In Ghana- Patient Level Direct Cost Analysis 2013 - 2016

    Oct 1, 2017, 00:00

  • Development of A New Patient-Reported Outcome Instrument To Evaluate Treatments For Stretchmarks- The Body-Q Stretchmark Scale

    Oct 1, 2017, 00:00

  • Distribuição Das Principais Neoplasias Malignas Segundo Sexo E Ano De Diagnóstico, Registro Hospitalar De Câncer, Instituto Do Câncer Do Estado De São Paulo, 2008-2012

    Oct 1, 2017, 00:00

  • Qualitative Interviews To Inform Development Of A Patient Reported Outcome (PRO) Strategy In RLBP1 Retinitis Pigmentosa (RLBP1 RP)

    Oct 1, 2017, 00:00

  • Nice’s New Budget Impact Threshold – What Proportion Of Drugs Is This Likely To Affect?

    Oct 1, 2017, 00:00

  • Cost of Type 2 Diabetes Management And Associated Complications In Spain

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Threshold in Brazil Through A League-Table Approach- Systematic Review

    Oct 1, 2017, 00:00

  • Costs And Effectiveness Of An Integrated Care Intervention For Muscle-Skeletal Diseases Transition From Primary Care To Specialized Hospital Care

    Oct 1, 2017, 00:00

  • Uso De Medicamentos Inapropriados Em Idosos Institucionalizados No Município De São Paulo, Brasil

    Oct 1, 2017, 00:00

  • The Influence Of Pharmaceutical Reform In Korea A Decade Ago- What We Walked

    Oct 1, 2017, 00:00

  • Appropriate Psoriatic Arthritis Treatment is Delayed for Years- Results From a Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Adherence to Anti-Convulsant Therapy Among Ambulatory Epileptic Patients in a Tertiary Hospital in Nigeria

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Daclizumab Beta In The Treatment of Relapsing Remitting Multiple Sclerosis In Italy

    Oct 1, 2017, 00:00

  • Análisis De Costo-Efectividad De La Monoterapia Con Rasagilina Comparada Con Pramipexol Para EL Manejo De Los Síntomas Motores En Pacientes Con Enfermedad De Parkinson Inicial En Colombia

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis Of Antihypertensive Dosage Adjustments By A Pharmacist In A Community Setting

    Oct 1, 2017, 00:00

  • Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) IN Patients With Type 2 Diabetes Mellitus In Serbia

    Oct 1, 2017, 00:00

  • Multiple Chronic Conditions in Older People and their Effects on Health Care Utilization- A Network Analysis Approach Using Share Data

    Oct 1, 2017, 00:00

  • Retrospective Study On Italian Adpkd Disease Management Cost (REINA STUDY)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Stereotaxic Eeg (SEEG) As A Preoperative Diagnostic Procedure In Epilepsy Surgery

    Oct 1, 2017, 00:00

  • Systematic Literature Review For Treatment Outcomes (Including Immuno-Oncology Treatment) Among Patients with Stage 3 Unresectable Non-Small Cell Lung Cancer (NSCLC)

    Oct 1, 2017, 00:00

  • Number Needed to Treat (NNT) and Cost of Preventing an Event (COPE) Comparison Between the Association of Cobimetinib and Vemurafenib Among Other Treatment Options for Metastatic Melanoma With BRAF V600 Mutation

    Oct 1, 2017, 00:00

  • Factors Contributing To The National Drug Expenditure Of Korea, 2010-2015- Focusing On The Core Therapeutic Classes

    Oct 1, 2017, 00:00

  • Estudos Econômicos De Belimumabe No Tratamento Do Lúpus Eritematoso Sistêmico - Uma Revisão Sistemática

    Oct 1, 2017, 00:00

  • The Evaluation Of Assumptions In Cost-Effectiveness Model Development – A Case Of Dabigatran

    Oct 1, 2017, 00:00

  • Comparative Efficacy And Safety Of Olaparib 300 Mg Tablets Bid And Niraparib 300 Mg Tablets QD As Maintenance Treatment After Response To Chemotherapy In Patients With Platinum-Sensitive Relapsed Germline BRCA-Mutated Ovarian Cancer (PSROC) ...

    Oct 1, 2017, 00:00

  • Value Communication Strategies for Immunotherapies in Nsclc- A Quick Evidence Assessment from The UK

    Oct 1, 2017, 00:00

  • Primary Prevention of Hyperlipidemia- Treatment and Compliance in Real World Practice

    Oct 1, 2017, 00:00

  • Incidence of Respiratory Syncytial Virus Related Healthcare Utilization In The United States

    Oct 1, 2017, 00:00

  • Pharmacy Workload And Workforce Requirement At Ministry Of Health Hospitals During Ten Years Mass Gathering Hajj (2006-2015) In Makah Region, Saudi Arabia

    Oct 1, 2017, 00:00

  • Economic Evaluation of Strategies for Opportunistic Cervical Cancer Screening

    Oct 1, 2017, 00:00

  • The Research And Suggestions On The Accessibility Of High Value Drugs In China

    Oct 1, 2017, 00:00

  • Outcomes of Disease Activity In Rheumatoid Arthritis and Health Insuran Results From Real World

    Oct 1, 2017, 00:00

  • The Effect of Changing Utility Elicitation Methods in Cardiovascular Disease- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Drug Utilization in a Cardiology Unit of a Referral Hospital in Nigeria

    Oct 1, 2017, 00:00

  • Statistical Trend Analysis of German Benefit Ratings And Their Correlation With Negotiated Rebates Focusing on Orphan Oncologics

    Oct 1, 2017, 00:00

  • Strategies To Effectively Prevent Surgical Site Infections In Italian Hospitals- Economic Benefits

    Oct 1, 2017, 00:00

  • Counterfactual Decomposition Of Health Care Expenditures- From Cost-Based Payment To Global Budget System

    Oct 1, 2017, 00:00

  • Un Marco Conceptual Para El Análisis De La Implementación De Los Componentes De La Salud Electrónica (E-Salud) Y Su Efecto En La Calidad En La Provisión De Servicios De Salud

    Oct 1, 2017, 00:00

  • Costs of Clinical Events in Diabetes Type 2 Patients in the Netherlands- A Systematic Review

    Oct 1, 2017, 00:00

  • Finding The Patient In Clinical Meaningfulness Through Rigorous Cognitive Interviews

    Oct 1, 2017, 00:00

  • Recruiting Metastatic Patients into Non-Small Cell Lung Cancer Studies (NSCLC)- Lessons Learned from A Non-Interventional Study of NSCLC Patients with Central Nervous System (CNS) Metastases (METS) and Non-CNS Mets

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Treatments For Hepatitis C Virus- What’s New?

    Oct 1, 2017, 00:00

  • Systematic Review of Herpes Zoster Epidemiology- Available Evidence In Spain Related To Specific Sub-Populations

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Nivolumab for The Treatment of People with Relapsed or Refractory Classical Hodgkin Lymphoma Following Autologous Stem Cell Transplant and Brentuximab Vedotin

    Oct 1, 2017, 00:00

  • Cost Of Hospitalizations For Nontuberculous Mycobacterial Pulmonary Disease In France In 2014- A PMSI Database Analysis

    Oct 1, 2017, 00:00

  • Validation of Surrogate Endpoints In Melanoma Therapies and Use In HTA

    Oct 1, 2017, 00:00

  • Effect Of Hesperidin In Bleomycin-Induced Pulmonary Fibrosis In Rats- Critical Role Of NRF-2, TNF-Α, AND IL-1Β

    Oct 1, 2017, 00:00

  • Quality of Life of Asthma Patients In Gree What Can We Do to Improve It?

    Oct 1, 2017, 00:00

  • Results Of Individual Participant Data Meta-Analysis VS Aggregate Data Meta-Analysis Of RCTS Of Exercise Rehabilitation In Chronic Heart Failure

    Oct 1, 2017, 00:00

  • The Prevalence and Treatment Status of Different Multiple Sclerosis Phenotypes in a Italian Reference Center

    Oct 1, 2017, 00:00

  • A Comparison Of Systemic Pediatric Fluoroquinolone Use In South Korea

    Oct 1, 2017, 00:00

  • The Impact Of Patient Preference Studies In The German Healthcare System

    Oct 1, 2017, 00:00

  • Burden of Hospitalizations Related To Spinal Tumors in Fran Evolution Between 2012 and 2014

    Oct 1, 2017, 00:00

  • Ameliorative Effect of Morin, A Bioflavonoid on Freund’s Adjuvant induced Established Polyarthritis in Rats

    Oct 1, 2017, 00:00

  • Skin-Based Temperature Measuring With Different Thermometer Types

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns In Metastatic And/Or Unresectable Gastric Cancer Patients In Russia

    Oct 1, 2017, 00:00

  • To Determine The Financial Imapct of Introducing Sc Rituximab (MABTHERA) vs. Currently used iv rituximab (MABTHERA) on The Budgets of Different Hospitals Across The Kingdom of Saudi Arabia (KSA)

    Oct 1, 2017, 00:00

  • Comparison Of Food And Drug Administration, European Medicine Agency And Swissmedic New Drug Approval- An Assessment Of The International Harmonization

    Oct 1, 2017, 00:00

  • Effect of Acrylic Monofocal Intraocular Lenses (IOLS) on ND-YAG Laser Capsulotomy Rates- A Meta-Analysis

    Oct 1, 2017, 00:00

  • Acceptance Of Indirect Comparisons In The German Early Benefit Assessment

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life, Work Productivity And Activity Impairment Associated With Clostridium Difficile Infection In China, Brazil, Europe and The United States

    Oct 1, 2017, 00:00

  • Outcomes And Costs Of Treating Hepatitis C With Direct-Acting Antivirals- Results From The German Hepatitis C-Registry

    Oct 1, 2017, 00:00

  • Real-World Prevalence Of Mild To Moderate Hypoglycemic Events In Portugal - Results From The Hipos-Pharma Study

    Oct 1, 2017, 00:00

  • Gender Differences In Heart Failure- The Arno Italian Experience

    Oct 1, 2017, 00:00

  • Analysis of Drug Utilisation Data Sources to Enable Nationwide Value-Based Pricing of Medicines Across Healthcare Systems in Europe

    Oct 1, 2017, 00:00

  • Anticonvulsant Drugs Use Evaluation Survey Among Ambulatory Epileptic Patients In A Tertiary Teaching Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • Meta-Análise De Eficácia Da Atomoxetina Em Adultos com Transtorno De Déficit Da Atenção Com Hiperatividade

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of four Surgical Strategies for the Treatment of Functional Menorrhagia in France

    Oct 1, 2017, 00:00

  • Expected Value of Information Analysis to Evaluate the Potential Gains of an RCT Comparing Wound Dressings

    Oct 1, 2017, 00:00

  • Determining The Comparative Value Of Outcome-Based Money-Back Guarantee Scenarios In Non-Small Cell Lung Cancer Using Real-World Data

    Oct 1, 2017, 00:00

  • Managed Access Agreements (MAAS) In Appraisals Conducted By The National Institute For Health and Care Excellence (NICE)

    Oct 1, 2017, 00:00

  • An Economic Evaluation Of Single Tablet Regimens Of Antiretroviral Therapy For Treatment-Naitve Hiv-Infected Patients

    Oct 1, 2017, 00:00

  • Health Economic Analysis Of Pneumococcal Conjugated Vaccines For Mexico, Under A Technical Parity Scenario

    Oct 1, 2017, 00:00

  • Application of Mixed-Method Study Designs in Health- Economic- Related Studies. A Narrative Review

    Oct 1, 2017, 00:00

  • Analysis Of The Reimbursement Amount And The Actual Costs For Infusion Of Immunobiologics In The Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Evidence Map of Indirect Costs In Psoriasis and Psoriatic Arthritis Since 1960

    Oct 1, 2017, 00:00

  • 90-Day Mortality And Its Predictors In Men With Contralateral Hip Fracture After Femoral Neck Fracture

    Oct 1, 2017, 00:00

  • The Two-Year Therapy with Omalizumab in Children with Severe Persistent Uncontrolled Asthma- Dynamics of Quality of Life

    Oct 1, 2017, 00:00

  • Do People With Private Health Insurance Attach A Higher Value To Health Than Those Without Insurance? Results From An EQ-5D-5L Valuation Study In The Republic Of Ireland

    Oct 1, 2017, 00:00

  • Preferences Of The General Public For Reimbursement Criteria For Expensive Drugs- A Multi Criteria Decision Analysis For Rituximab And Bevacizumab

    Oct 1, 2017, 00:00

  • Mechanisms Of Trade Margin Regulation Of Prescription Drugs- Comparison Of 15 Eu Countries

    Oct 1, 2017, 00:00

  • Predicting Budget Impact- A Mixed-Effects Model Approach

    Oct 1, 2017, 00:00

  • FOLLOW-UP OF PEDIATRIC PATIENTS UNDER TREATMENT WITH SOMATROPIN IN BRAZIL THROUGH A PATIENT SUPPORT PROGRAM (PSP)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared to Conventional Treatment From A Societal Perspective In Germany, France, Italy And The UK

    Oct 1, 2017, 00:00

  • Antineoplásicos De Maior Impacto Financeiro No Instituto Nacional De Cancer Do Brasil

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Ayahuasca Treatment For Substance Use Disorder (SUD) Patients In A Peruvian Centre

    Oct 1, 2017, 00:00

  • Preoperative Smoking Cessation- Recording of Smoking Status in the Porvoo Hospital Area in Finland

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62
  • 63
  • 64 (current)
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • »